Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothesis: how licensed vaccines confer protective immunity

J B Robbins1, R Schneerson, S C Szu

  • 1Laboratory of Developmental and Molecular Immunity National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892, USA.

Advances in Experimental Medicine and Biology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extra credit for disruption: trend of disruption in radiology academic journals.

Clinical radiology·2022
Same author

Adnexal lesions: Imaging strategies for ultrasound and MR imaging.

Diagnostic and interventional imaging·2018
Same author

An outbreak of Salmonella Paratyphi A in a boarding school: a community-acquired enteric fever and carriage investigation.

Epidemiology and infection·2010
Same author

Haemoglobin O in An Arab Family.

British medical journal·2010
Same author

Mesenteric venous collateral vessels mimicking cystic pancreatic neoplasm.

The British journal of radiology·2010
Same author

Electrostatic interactions and secondary structures in proteins.

Biophysical journal·2009
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Serum immunoglobulin G (IgG) antibodies are key to vaccine protection, preventing infectious diseases by neutralizing pathogens. This understanding simplifies vaccine development by reducing the need to study disease symptoms.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Licensed vaccines rely on inducing protective immune responses.
  • Understanding the precise mechanisms of vaccine-induced protection is crucial for development.
  • Serum antibodies, particularly immunoglobulin G (IgG), are known mediators of immunity.

Purpose of the Study:

  • To propose and support a theory that a critical level of serum IgG confers protection against infectious diseases.
  • To elucidate the role of serum antibodies in vaccine efficacy and herd immunity.
  • To suggest that understanding disease pathogenesis may not be essential for vaccine development.

Main Methods:

  • Reviewing existing data from licensed vaccine evaluations.
  • Analyzing the correlation between serum antibody levels and vaccine efficacy.

Related Experiment Videos

  • Examining the contribution of serum IgG to passive immunization.
  • Evaluating the role of serum antibodies in epithelial surfaces for herd immunity.

    • Main Results:

    • Vaccine efficacy is reliably predicted by measuring elicited serum antibodies.
    • Serum IgG antibodies alone are sufficient for protection in passive immunization.
    • Vaccine-induced herd immunity is explained by serum antibody-mediated inactivation of pathogens on epithelial surfaces.
    • Active immunization-induced serum antibodies do not treat disease symptoms or eliminate pathogens.

    Conclusions:

    • A critical level of serum IgG is theorized to confer protection against infectious diseases.
    • Serum antibody measurement is a reliable predictor of vaccine efficacy.
    • This theory simplifies vaccine development by potentially decoupling it from detailed knowledge of disease pathogenesis.